Laryngeal cancer survival in Zaragoza (Spain): a population-based study
- PMID: 22374426
- DOI: 10.1007/s12094-012-0787-1
Laryngeal cancer survival in Zaragoza (Spain): a population-based study
Abstract
Objective: This article aims to study larynx cancer survival from the Population-Based Cancer Registry of Zaragoza, Spain, for the period 1978-2002.
Methods: The survival rates were calculated using the Kaplan-Meier method. The automated calculation of the Catalan Institute of Oncology was utilised to obtain the relative survival.
Results: The observed survival rate was 84.6% in the first year and 60.9% in the fifth year. The one-year relative survival in both genders was 86.8% (CI 95%: 85.3-88.4) and 70.1% (CI 95%: 67.8-72.4) after five years. Glottic cancer presented a better survival rate than supraglottic and subglottic cancers, and a better survival rate was also observed in younger ages. There were no statistical differences when comparing survival rates by gender and between the periods 1978-1986, 1987-1994 and 1995-2002.
Conclusions: The data suggest there were no significant changes in laryngeal cancer survival in the province of Zaragoza in the period 1978-2002 and that the tumours located in the glottis presented a better prognosis.
Similar articles
-
Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.Head Neck. 2016 Jul;38(7):1107-12. doi: 10.1002/hed.24424. Epub 2016 Mar 11. Head Neck. 2016. PMID: 26970262
-
Impact of stage, management and recurrence on survival rates in laryngeal cancer.PLoS One. 2017 Jul 14;12(7):e0179371. doi: 10.1371/journal.pone.0179371. eCollection 2017. PLoS One. 2017. PMID: 28708883 Free PMC article.
-
Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.Otolaryngol Head Neck Surg. 2015 Jul;153(1):54-9. doi: 10.1177/0194599815581613. Epub 2015 Apr 27. Otolaryngol Head Neck Surg. 2015. PMID: 25917664
-
Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers.Head Neck. 2012 Jul;34(7):1028-35. doi: 10.1002/hed.21766. Epub 2011 Apr 15. Head Neck. 2012. PMID: 21500310 Review.
-
Causes of death of patients with laryngeal cancer.Eur Arch Otorhinolaryngol. 2014 Mar;271(3):425-34. doi: 10.1007/s00405-013-2478-0. Epub 2013 Apr 17. Eur Arch Otorhinolaryngol. 2014. PMID: 23591796 Review.
Cited by
-
Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma.J Exp Clin Cancer Res. 2012 Dec 12;31(1):101. doi: 10.1186/1756-9966-31-101. J Exp Clin Cancer Res. 2012. PMID: 23231769 Free PMC article.
-
Contribution of TIP30 to chemoresistance in laryngeal carcinoma.Cell Death Dis. 2014 Oct 16;5(10):e1468. doi: 10.1038/cddis.2014.424. Cell Death Dis. 2014. PMID: 25321475 Free PMC article.
-
Survival of patients with subglottic squamous cell carcinoma.Curr Oncol. 2018 Dec;25(6):e569-e575. doi: 10.3747/co.25.3864. Epub 2018 Dec 1. Curr Oncol. 2018. PMID: 30607125 Free PMC article.
-
Lentivirus‑delivered nemo‑like kinase small interfering RNA inhibits laryngeal cancer cell proliferation in vitro.Mol Med Rep. 2015 Oct;12(4):5619-24. doi: 10.3892/mmr.2015.4189. Epub 2015 Aug 6. Mol Med Rep. 2015. PMID: 26252054 Free PMC article.
-
Investigation of biomarker in laryngeal carcinomas.J Clin Lab Anal. 2014 May;28(3):186-90. doi: 10.1002/jcla.21664. Epub 2014 Jan 6. J Clin Lab Anal. 2014. PMID: 24395286 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical